sunil j advani

sunil j advani

University of California, San Diego

H-index: 31

North America-United States

About sunil j advani

sunil j advani, With an exceptional h-index of 31 and a recent h-index of 17 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of cancer biology, radiation sensitivity, gene therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Antibody Drug Conjugate Targeted Radio-Immunosensitization

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

A FZD7-specific antibody–drug Conjugate induces ovarian Tumor Regression in Preclinical Models

Establishment of patient-derived succinate dehydrogenase–deficient gastrointestinal stromal tumor models for predicting therapeutic response

Targeting FZD7-positive cancers using a novel antibody-drug conjugate

Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs

Redirecting tumor extracellular proteases to target radiosensitizer delivery

Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors

sunil j advani Information

University

Position

assoc prof of radiation oncology

Citations(all)

3023

Citations(since 2020)

906

Cited By

2398

hIndex(all)

31

hIndex(since 2020)

17

i10Index(all)

47

i10Index(since 2020)

26

Email

University Profile Page

Google Scholar

sunil j advani Skills & Research Interests

cancer biology

radiation sensitivity

gene therapy

Top articles of sunil j advani

Antibody Drug Conjugate Targeted Radio-Immunosensitization

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Nature communications

2022/7/5

Zhiyong Wang
Zhiyong Wang

H-Index: 9

Sunil J Advani
Sunil J Advani

H-Index: 16

A FZD7-specific antibody–drug Conjugate induces ovarian Tumor Regression in Preclinical Models

Molecular cancer therapeutics

2022/1/1

Charmi Patel
Charmi Patel

H-Index: 0

Sunil J Advani
Sunil J Advani

H-Index: 16

Establishment of patient-derived succinate dehydrogenase–deficient gastrointestinal stromal tumor models for predicting therapeutic response

Clinical Cancer Research

2022/1/1

Targeting FZD7-positive cancers using a novel antibody-drug conjugate

Cancer Research

2021/7/1

Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs

Pharmaceutics

2021/3/10

Sunil J Advani
Sunil J Advani

H-Index: 16

Redirecting tumor extracellular proteases to target radiosensitizer delivery

Cancer Research

2020/8/15

Sunil J Advani
Sunil J Advani

H-Index: 16

Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors

Biomaterials

2020/7/1

Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof

2020/3/24

Precision chemoradiotherapy for HER2 tumors using antibody conjugates of an auristatin derivative with reduced cell permeability

Molecular cancer therapeutics

2020/1/1

Sunil J Advani
Sunil J Advani

H-Index: 16

See List of Professors in sunil j advani University(University of California, San Diego)